Introduction
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Microbial diseases are increasing day by day and becoming the big problem for human 33 health. There are more than 200 known diseases which is transmitted by bacteria, fungi, 34 viruses, prions and other microbes to human being. The emergence of drug and multidrug 35 resistant pathogens is the biggest issues, therefore, novel antimicrobial agents from natural 36 resources with novel mechanism of actions are required in biopharmaceutical industry. Many 37 research work has been carried out to control the pathogens and to identify the novel 38 antimicrobial agents. Microbes from the soil samples are the most common natural sources 39 exhibiting the strong biological activities against various pathogens. In general, microbes 40 produces bioactive compounds which can be useful in defence mechanism. Antimicrobial 41 agents are synthetic or natural substances used to destroy or prevent the growth of bacteria, 42 viruses and other micro-organisms (antibiotics are microbial agents which only react against 43 bacteria). These substances have played a significant role improving public health by helping 44 to reduce the number of deaths from diseases and infections which were previously incurable 45 or fatal. Almost all of the living organisms have the ability to produce secondary metabolites. 46 Overall, it has been observed that unicellular bacteria, eukaryotic fungi, and filamentous 47 actinomyces are the most frequent and versatile producers. Oxytetracycline. Also the selected isolates were screened for polyketide identified. This will 72 be an urgent needful research in current scenario of antimicromibial chemotherapy and drug 73 discovery from microbial origin. Further studies on the bioactive metabolites from these 74 cultures will be useful for discovering novel compounds of clinical and agricultural use. 
Isolation of Actinomycetes from soil samples 81
The isolation of Actinomycetes was done by serial dilution method. One gram of soil was 82 suspended in 9 ml of sterile double distilled water. The dilution was carried out up to 10 -5 83 dilutions. Aliquots of 1000µl were taken and spread on the Actinomycetes medium and 84 incubated at 30 0 C for 7-10 days. Based on the colony growth the Actinomycetes were 85 selected and studied further using ISP2 The antimicrobial activity of isolated Actinomycetes were performed by cross streak method.
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The plates were prepared and inoculated with isolated by single streak at the centre of petri 96 dish and incubated at 30 0 C for 3 days. the palates were then inoculated with test organism by 97 a single streak at 90 0 angle to the Actinomycetes strains and incubated at 37 0 C overnight.
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Then the antogonism of test organism was recorded. isolates grown at the centre of the plates and further perpendicularly the pathogen strain were 178 incubated for 24 hours to observe their antibacterial effect. The control plates without the 179 Actinomycetes isolates were also prepared to compare the similar pattern of growth (Fig. 2) .
180
The MIC value were measured in mm. Among 121 isolates of Actinomycetes there was a 
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A1 is TK-01-04 , A2 is TK-01-05, A3 is TK-08-22, and A4 is SVG-07-05. shown to have significant effect against human pathogens such as S. aureus (Fig. 6) . The screening of soil bacteria for novel bioactive compounds, for the antibacterial activity, 255 tends to enrich compounds that are already known and abundantly present in environment.
256
Around 23,000 bioactive secondary metabolites produced by the different microorganisms 257 almost 10,000 of these compounds are produced by Actinomycetes. A wide range of 258 antibiotics in the market obtained from Actinomycetes. For novel drug delivery, researchers 259 still exploiting the chemical and biological diversity from diverse Actinomycetes group to 260 maximize the possibility of successful discovery of isolates in cost effective manner. 
